ixazomib,daratumumab,pomalidomide,dexamethasone
takeda,janssen,bms,
ixazomib regimen induces high response rates, proves tolerable in relapsed/refractory multiple myeloma #ims2022 #mmsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.